Ε.Ε.Ε.Ε.Π.

Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 65 years and older, ECDC multi-country study

—

by

in

This document reports the first interim pooled estimates from the ECDC study of COVID-19 vaccine effectiveness
(VE).